Search Prime Grants

R01HG014077

Project Grant

Overview

Grant Description
Computational and experimental approaches to decode domain-specific protein-RNA interactions - Computational and experimental approaches to decode domain-specific protein-RNA interactions.

Project summary

RNA-binding proteins (RBPs) play central roles in post-transcriptional gene regulation by diversifying the types and levels of protein products expressed in specific cellular contexts.

This is achieved through interactions of RBPs with specific sequence or structural elements in their target transcripts.

Disruption of these regulatory elements accounts for a substantial fraction of human disease associations.

However, since most of these elements are embedded in the noncoding genomic regions, they are currently annotated poorly in the human genome.

While CLIP-Seq and its many variants can map RBP binding footprints on a genome-wide scale, such maps remain sparse in coverage concerning both the number of RBPs and cell types.

Predictive computational models can potentially complement experimental data and provide powerful tools to interpret the functional impact of genetic variants, but the success of this approach is still limited.

We realize that a major challenge in the precise mapping and prediction of protein-RNA interactions is a critical lack of technologies that can delineate the specificity of individual RNA-binding domains (RBDs) of multi-domain RBPs, which account for about half of all RBPs in humans.

Since the current CLIP methods pull down all RNA fragments crosslinked to any RBDs in a mixed population, with each individual RBD recognizing short and degenerate motif sites, we are unable to deconvolute the binding sites of individual RBDs.

Such resolution is required to precisely understand the mechanisms conferring the specificity of protein-RNA interactions and interpret the functional significance of genetic variants.

In this study, we propose two complementary strategies to overcome the fundamental challenge and develop new methods that will enable one to map domain-specific protein-RNA interactions in the native cellular context, at single-nucleotide resolution, on a genome-wide scale.

This project builds on the tight integration of complementary expertise of the Zhang Lab in RNA and computational biology and Wang Lab in chemical biology.

If successful, this study will produce platform technologies that will find impactful applications in studies of gene expression regulation, genotype-phenotype relationships, and development of RNA-based precision genetic medicine.
Funding Goals
AS A LEADING AUTHORITY IN THE FIELD OF GENOMICS, THE MISSION OF THE NATIONAL HUMAN GENOME RESEARCH INSTITUTE (NHGRI) IS TO ACCELERATE SCIENTIFIC AND MEDICAL BREAKTHROUGHS THAT IMPROVE HUMAN HEALTH BY DRIVING CUTTING-EDGE RESEARCH, DEVELOPING NEW TECHNOLOGIES, AND STUDYING THE IMPACT OF GENOMICS ON SOCIETY. CONGRESS INITIALLY ESTABLISHED NHGRI TO CHARACTERIZE THE STRUCTURE AND FUNCTION OF THE HUMAN GENOME, INCLUDING THE MAPPING AND SEQUENCING OF INDIVIDUAL GENES. THIS ALSO INCLUDES REVIEWING AND FUNDING RESEARCH PROPOSALS, DEVELOPING TRAINING PROGRAMS, COORDINATING INTERNATIONAL GENOME RESEARCH, COMMUNICATING ADVANCES IN GENOME SCIENCE TO THE PUBLIC, AND REVIEWING AND FUNDING PROPOSALS TO ADDRESS THE ETHICAL AND LEGAL ISSUES ASSOCIATED WITH THIS RESEARCH.NHGRI SUPPORTS THE DEVELOPMENT OF METHODS, RESOURCES AND TECHNOLOGIES TO IMPROVE THE HEALTH OF ALL HUMANS THROUGH ADVANCES IN GENOMICS RESEARCH. NHGRI SUPPORTS RESEARCH THAT ACCELERATES FOUNDATIONAL RESOURCES, TECHNOLOGY DEVELOPMENT, AND EXPERIMENTAL AND COMPUTATIONAL APPROACHES FOR BASIC GENOMICS AND FUNCTIONAL GENOMICS RESEARCH; FOR THE APPLICATION OF GENOMICS TO MEDICAL SCIENCE AND CLINICAL CARE; AND TO SUPPORT ETHICAL, LEGAL AND SOCIAL IMPLICATIONS (ELSI) RESEARCH CONCERNING SOCIETAL ISSUES THAT NEED TO BE ADDRESSED, ESPECIALLY AS GENOMIC SCIENCE ADVANCES. FOR YEARS, NHGRI HAS PARTICIPATED IN THE NIH EFFORT TO TURN DISCOVERY INTO HEALTH BY HELPING SMALL BUSINESSES DEVELOP INNOVATIVE GENOMICS TECHNOLOGIES THAT IMPROVE HEALTH AND SAVE LIVES. NHGRI ALSO DEVELOPS AND SUPPORTS INITIATIVES THAT EXPAND OPPORTUNITIES FOR GENOMICS EDUCATION AND CAREERS, CULTIVATING GENOMICS TRAINING PROGRAMS AND WORKFORCE DEVELOPMENT INITIATIVES.
Grant Program (CFDA)
Place of Performance
New York United States
Geographic Scope
State-Wide
The Trustees Of Columbia University In The City Of New York was awarded Decoding Domain-Specific Protein-RNA Interactions Project Grant R01HG014077 worth $3,243,342 from National Human Genome Research Institute in April 2026 with work to be completed primarily in New York United States. The grant has a duration of 4 years and was awarded through assistance program 93.172 Human Genome Research. The Project Grant was awarded through grant opportunity NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed).

Status
(Ongoing)

Last Modified 4/6/26

Period of Performance
4/1/26
Start Date
3/31/30
End Date
4.0% Complete

Funding Split
$3.2M
Federal Obligation
$0.0
Non-Federal Obligation
$3.2M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to R01HG014077

Additional Detail

Award ID FAIN
R01HG014077
SAI Number
R01HG014077-3143042669
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75N400 NIH National Human Genome Research Institute
Funding Office
75N400 NIH National Human Genome Research Institute
Awardee UEI
QHF5ZZ114M72
Awardee CAGE
3FHD3
Performance District
NY-90
Senators
Kirsten Gillibrand
Charles Schumer
Modified: 4/6/26